KIDNEY TRANSPLANT REJECTION
Clinical trials for KIDNEY TRANSPLANT REJECTION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT REJECTION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug may unlock transplants for Hard-to-Match kidney patients
Disease control Not yet recruitingThis study tests if the drug belimumab can help find more compatible donor kidneys for highly sensitized patients waiting for a transplant. About 25 adults will receive a short course of belimumab to see if it improves detection of immune cells that react against donor kidneys. T…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: PHASE2 • Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
Stem cell therapy fails to help kidney rejection, raises safety flags
Disease control Not yet recruitingThis study tested whether a patient's own stem cells (MSCs) could help treat chronic active antibody-mediated rejection in kidney transplant recipients. Only 3 people were treated before the study was stopped early due to serious side effects. The treatment did not improve reject…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: NA • Sponsor: Shahid Beheshti University of Medical Sciences • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
New hope for kidney transplant patients: early rejection treatment aims to save grafts
Disease control Not yet recruitingThis study looks at a new way to treat early antibody-mediated rejection in kidney transplant patients who develop donor-specific antibodies after transplant. About 290 adults will be randomly assigned to either switch to belatacept plus standard care or stay on their current med…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC
-
AI takes on kidney transplant rejection in new pilot trial
Disease control Not yet recruitingThis pilot study tests whether an AI-based system can help doctors choose the right doses of immunosuppressant drugs for kidney transplant patients. The goal is to protect the new kidney from damage and rejection. The study will enroll 34 adults who have received a deceased donor…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: NA • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 09, 2026 12:09 UTC
-
New blood test could spare kidney transplant patients unnecessary biopsies
Knowledge-focused Not yet recruitingThis study watches 600 kidney transplant patients to see if a special blood test (TruGraf and TRAC) can help doctors manage anti-rejection medicines better. The goal is to reduce the need for invasive kidney biopsies and catch problems early. Participants will be followed for 24 …
Matched conditions: KIDNEY TRANSPLANT REJECTION
Sponsor: Transplant Genomics, Inc. • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:54 UTC